AMLODIPINE BESYLATE USP
GMP 7 Inquiries
111470-99-6
Pharmaceutical Grade
Mumbai
1.0kg
2024-07-25
4-Chloro-7-tosyl- 7H-pyrrolo[2,3- d]pyrimidine
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionCertificatesBasic Info
-
Product Name:
Amlodipine Besylate
Other Name:Vazkor;3-Ethyl 5-Methyl 2-(2-Aminoethoxy)methyl-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate Benzenesulfonate 2-(2-Aminoethoxy)methyl-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylic Acid 3-Ethyl 5-Methyl Ester Benzenesulfona;3-ethyl 5-Methyl 2-((2-aMinoethoxy)Methyl)-4-(2-chlorophenyl)-6-Methyl-1,4-dihydropyridine-3,5-dicarboxylate benzenesulfonate;AMlodipine bes;Amlodipine besilate (crystalline);2-[(2-Aminoethoxy)methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylic acid 3-ethyl 5-methyl ester benzenesulfonate;raw material amlodipine besylate;Amlodipine Beaylate
CAS No.:111470-99-6
Molecular Formula:C20H25ClN2O5.C6H6O3S
InChIKeys:ZPBWCRDSRKPIDG-UHFFFAOYSA-N
Molecular Weight:567.05
Exact Mass:566.149
EC Number:1312995-182-4
NSC Number:758922
DSSTox ID:DTXSID2043909
Color/Form:white
ATC Code:C09DB01|C09DX01|QC08CA01
HScode:29333990
Categories:
Characteristics-
PSA:
163
XLogP3:5.30950
Appearance:white solid
Density:1.227g/cm3
Melting Point:199-201°C
Boiling Point:527.2°C at 760 mmHg
Flash Point:272.6ºC
Water Solubility:Soluble in DMSO (20 mg/mL), water (10 mM), chloroform, ethanol (14 mg/mL), and methanol.
Storage Conditions:Store at RT
Vapor Pressure:3.34E-11mmHg at 25°C
PKA:8.6
Collision Cross Section:187.4 Ų [M+H]+ [CCS Type: TW, Method: calibrated with polyalanine and drug standards]
Critical Temperature & Pressure:2-8°C
Hazard IdentificationClassification of the substance or mixture
Acute toxicity - Category 4, Oral
Skin irritation, Category 2
Eye irritation, Category 2
Specific target organ toxicity â single exposure, Category 3
GHS label elements, including precautionary statements
Pictogram(s) 
Signal word Warning
Hazard statement(s) H302 Harmful if swallowed
H315 Causes skin irritation
H319 Causes serious eye irritation
H335 May cause respiratory irritation
Precautionary statement(s) Prevention P264 Wash ... thoroughly after handling.
P270 Do not eat, drink or smoke when using this product.
P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...
P261 Avoid breathing dust/fume/gas/mist/vapours/spray.
P271 Use only outdoors or in a well-ventilated area.
Response P301+P317 IF SWALLOWED: Get medical help.
P330 Rinse mouth.
P302+P352 IF ON SKIN: Wash with plenty of water/...
P321 Specific treatment (see ... on this label).
P332+P317 If skin irritation occurs: Get medical help.
P362+P364 Take off contaminated clothing and wash it before reuse.
P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P304+P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing.
P319 Get medical help if you feel unwell.
Storage P403+P233 Store in a well-ventilated place. Keep container tightly closed.
P405 Store locked up.
Disposal P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Distributor
-
Main Products:
4-Chloro-7-tosyl- 7H-pyrrolo[2,3- d]pyrimidine
-
Location:
Rajkot 360007, Gujarat, INDIA
-
Payment Terms:
TT against copy of documents,L/C,100% TT in advance
-
Average lead Time:
20
-
Total Annual Revenue:
Less than $1 million
-
Total Employees:
5-10
-
Year of Establishment:
2024
-
-
Inquiry History7 Inquiries
Country Product Purchase Quantity Date Posted 
United States
Amlodipine (generic Norvasc) besylate
100 G Jun 12, 2024 
Philippines
Amlodipine Besilate
1000 KG Jun 1, 2026 
Pakistan
Amlodipine Besilate USP
35 KG Mar 12, 2024
Pakistan
Amlodipine Besylate
25 KG Jul 9, 2025
United States
Olanzapine (generic Zyprexa)
100 G Jun 12, 2024
United States
Paliperidone (generic Invega)
100 G Jun 12, 2024
United States
Imiquimod (generic Aldara)
100 G Jun 12, 2024 Post an enquiry for this product